Dietary Supplements for Dementia, Alzheimers ‘Like the Wild West’: Senator

Dietary supplements sold by many online retailers that claim to treat or prevent Alzheimers, dementia and memory loss may be preying on vulnerabilities of older Americans, according to a prominent U.S. Senator.

In a press release issued this week, U.S. Senator Claire McCaskill announced a new campaign against dietary supplements that exploit senior citizens suffering from memory loss or other related ailments.

McCaskill is the ranking member of the Senate Special Committee on Aging, which often investigates health scams targeting older Americans. The statement specifically mentions the dietary supplement “Brain Armor”, which is allegedly targeted to seniors suffering from Alzheimers, dementia and memory loss, but similar supplements are marketed under various different brand names as well, such as “Brain Awake” and “Dementia Drops”.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Letters were sent by the Senator to at least 15 major retailers, including Amazon, QVC, Walgreens, Home Shopping Network, Walmart, Target, CVS, Vitamin Shoppe, Safeway, eBay, Kroger, Vitamin World, GNC, Google, and Yahoo, asking about policies regarding the sale and marketing of dietary supplements. The letters also asked companies to explain how they evaluate whether or not dietary supplement manufacturers are making false claims.

“Brain Armor” was sold on Amazon until McCaskill alerted the FDA to the manufacturer’s claims that the supplement protects against Alzheimer’s, dementia and stroke. It was then pulled from the website. However, similar products continue to be sold on Amazon and several other national retailerโ€™s websites.

โ€œPeople looking online for cures or treatment for Alzheimerโ€™s Disease and dementia are at their most desperateโ€”and itโ€™s clear from what weโ€™ve found that many of these products prey on that desperation,โ€ McCaskill said in her press release. โ€œRight now itโ€™s like the wild west when it comes to the production, marketing, distribution, and sale of these products. I want to figure out why that is and what we can do to better protect Americaโ€™s seniors.โ€

In a letter sent to the FDA, McCaskill called on the agency to fulfill its obligation to prevent fraud and to review new supplements and ingredients. McCaskill focused on the enforcement actions of the FDA and those specifically taken against dietary supplement manufacturers and distributors that fail to comply with regulations.

The letter called for a detailed description of the FDAโ€™s process for evaluation of medical and nutritional claims made by supplements already on the market and what the agency has done to prevent fraudulently marketed products from being sold in stores and websites.

โ€œItโ€™s important that these companies respect their customers in turn by doing what they can to not sell products that are unsafe or misleading,โ€ she said.

McCaskill said the FDA lacks a โ€œsystematic approachโ€ to preventing potentially harmful products from entering the market.

This is the latest investigation into the dietary supplement industry, which is a $30 billion industry and includes thousands of products which have often been under scrutiny concerning questionable advertising, marketing and manufacturing practices.

Dietary supplements are not subject to FDA regulation as long as they make no claim to cure or treat a condition. The only time the FDA intervenes is when the ingredients actually include an FDA-controlled substance, they make a claim to treat a medical condition, or there has been a health problem linked to the use of the supplement. .

More than 5 million people suffer from Alzheimerโ€™s in the U.S. It is the most common form of dementia, according to the U.S. Centers for Disease Control and Prevention. There is no known cure for the conditions and prescription drugs only ease the symptoms.

Written by: Martha Garcia

Health & Medical Research Writer

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Plaintiffs and defendants involved in hair relaxer cancer lawsuits are expected to turn in a list of 12 cases that the parties believe are fit to serve as bellwether trials.
Cartiva implant lawsuits are moving forward in federal court as patients across the United States seek compensation for complications linked to the recalled big toe device.
An Abbott spinal cord stimulator lawsuit filed by three women says the product was defectively designed, inappropriately approved by the FDA, and left them with severe injuries, worsening pain and the need for removal surgery.